tiprankstipranks
Immuneering Corp. Class A (IMRX)
NASDAQ:IMRX
US Market
IMRX
Immuneering
RESEARCH TOOLSreports
Want to see IMRX full AI Analyst Report?

Immuneering (IMRX) Balance Sheet

660 Followers

Immuneering Balance Sheet

Immuneering's total assets for Q1 2026 were $214.81B, an increase of 92496.41% from the previous quarter. IMRX total liabilities were $8.29B for the fiscal quarter, a 61314.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 231.99M$ 52.71M$ 102.58M$ 122.37M$ 166.70M
Total Liabilities
$ 13.50M$ 11.33M$ 12.01M$ 12.52M$ 10.72M
Total Equity Gross Minority
$ 218.48M$ 41.39M$ 90.58M$ 109.85M$ 155.98M
Other Metrics
Currency in USD

Immuneering Debt to Assets